期刊文献+

Sequence Variation in the Gp120 region of SHIV-CN97001 during in vivo Passage 被引量:6

Sequence Variation in the Gp120 region of SHIV-CN97001 during in vivo Passage
下载PDF
导出
摘要 SHIV-CN97001 played an important role in assessing the immune effect and strategy of the AIDS vaccine which included genes of the predominant prevalent HIV-1 strain in China. In this study, SHIV-CN97001 was in vivo passaged serially to construct pathogenic SHIV-CN97001/rhesus macaques model. To identify variation in the gp120 region of SHIV-CN97001 during passage, the fragments of gp120 gene were amplified by RT-PCR from the plasma of SHIV-CN97001 infected animals at the peak viral load time point and the gene distances (divergence, diversity) were calculated using DISTANCE. The analysis revealed that the genetic distances of SHIV-CN97001 in the third passage animals were the highest during in vivo passage. It had a relationship between viral divergence from the founder strain and viral replication ability. The nucleic acid sequence of the V3 region was highly conservative. All of the SHIV-CN97001 strains had V3 loop central motif (GPGQ) and were predicted to be using CCR5 co-receptor on the basis of the critical amino acids within V3 loop. These results show that there was no significant increase in the genetic distance during serial passage, and SHIV-CN97001 gp120 gene evolved toward ancestral states upon transmission to a new host. This could partly explain why there was no pathogenic viral strain obtained during in vivo passage. SHIV-CN97001 played an important role in assessing the immune effect and strategy of the AIDS vaccine which included genes of the predominant prevalent HIV-1 strain in China. In this study, SHIV-CN97001 was in vivo passaged serially to construct pathogenic SHIV-CN97001/rhesus macaques model. To identify variation in the gp120 region of SHIV-CN97001 during passage, the fragments of gp120 gene were amplified by RT-PCR from the plasma of SHIV-CN97001 infected animals at the peak viral load time point and the gene distances (divergence, diversity) were calculated using DISTANCE. The analysis revealed that the genetic distances of SHIV-CN97001 in the third passage animals were the highest during in vivo passage. It had a relationship between viral divergence from the founder strain and viral replication ability. The nucleic acid sequence of the V3 region was highly conservative. All of the SHIV-CN97001 strains had V3 loop central motif (GPGQ) and were predicted to be using CCR5 co-receptor on the basis of the critical amino acids within V3 loop. These results show that there was no significant increase in the genetic distance during serial passage, and SHIV-CN97001 gp120 gene evolved toward ancestral states upon transmission to a new host. This could partly explain why there was no pathogenic viral strain obtained during in vivo passage.
出处 《Virologica Sinica》 SCIE CAS CSCD 2008年第1期8-14,共7页 中国病毒学(英文版)
基金 CIPRA (U19 AI051915) 973 (2005CB-522903).
关键词 体内通道 Gpl20 变异 序列分析 艾滋病病毒 免疫因子 SHIV SHIV Passage Gp120 Variation Sequence analysis
  • 相关文献

参考文献11

  • 1梁浩,魏民,陈钊,邢辉,赵全壁,冯毅,关琪,施侣元,邵一鸣.中国HIV-1型B、C亚型主要流行株外膜蛋白基因V3-V4区序列的变异分析[J].中华实验和临床病毒学杂志,2003,17(2):153-158. 被引量:9
  • 2Balfe P,Shapiro S,Hsu M, et al.Expansion ofquasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques[].Virology.2004
  • 3Herbeck J T,Nickle D C,Learn G H, et al.Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host[].J Virol.2006
  • 4Narayan S V,Mukherjee S,Jia F, et al.Characteri- zation of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques[].Virology.1999
  • 5Nowak M A,Anderson R M,Mclean A R, et al.Antigenic diversity thresholds and the development of AIDS[].Science.1991
  • 6Regina H L,Ryan K S,Vladimir L, et al.Sensitive and Robust One-Tube Real-Time Reverse Transcriptase- Polymerase Chain Reaction to Quantify SIV RNA Load: Comparison of One-versus Two-Enzyme Systems[].AIDS.2000
  • 7Trichel A M,Rajakumar P A,Murphy-Corb M, et al.Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque[].J Med Primatol.2002
  • 8Ui M,Kuwata T,Igarashi T, et al.Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs[].Virology.1999
  • 9Harouse JM,Gettie A,Tan RC,et al.Distinct pathogenic sequela in rhesus macaques infected with CCR5or CXCR4utilizing SHIVs[].Science.1999
  • 10Kumar A,Lifson J D,Li Z,et al.Sequential immunization of macaques with two differentially attenuated vaccines induced longterm virus-specific immune responses and conferred protection against AIDS caused by heterologous simian immunodeficiency virus(SHIV-89. 6P)[].Journal of Virology.2001

二级参考文献8

  • 1中国疾病预防控制中心性病艾滋病预防与控制中心.全国艾滋病疫情[J].艾滋病预防控制信息,2002,1.
  • 2Guinones-Mateu M, Arts E. Recombination in HIV-I :Update and implications. AIDS Rev, 1999, 1:89-100.
  • 3Li WH. Unbiased estimation of the rates of synonymous and nonsynonymous substitution. J Mol Evol, 1993,36:96-99.
  • 4Su L, Graf M, Zhang Y, et al. Characterization of a virtually full-length human immunodeficiency virus type I genome of a prevalent intersubtype(C/B') recombinant strain in China. J Virol, 2000,74:11367-11376.
  • 5Piyasirisilp S, McCutchan FE, Cart JK, et al. A recent outbreak of human immunodeficiency virus type I infection in southern China was initiated by two highly homogeneous, geographically separated strains,circulating recombination form AE and a novel BC recombinant. J Virol,2000, 74:11286-11295.
  • 6Oelrichs RB, Shrestha IL, Anderson DA, et al.The explosive human immunodeficiency virus type I epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J Virol, 2000,74:1149-1157.
  • 7Simmonds P, Balfe P, Ludlam CA, et al. Analysis of sequence diversity in hypervariable region of the external glycoprotein of human immunodeficiency virus type I. J Virol, 1990, 64:5840-5850.
  • 8Zhang L, Diaz RS, Ho DD, et al. Host-specific driving force in human immunodeficiency virus type I evolution in vivo. J Virol, 1997,71:2555-2.561.

共引文献8

同被引文献31

引证文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部